CVRX INC. - COMMON STOCK

CVRx to Report First Quarter 2023 Financial and Operating Results and Host Conference Call on April 27th, 2023

20 Apr 2023 16:30:00 By Nasdaq GlobeNewswire

Totality of Evidence from BeAT-HF Study Shows CVRx’s Barostim Provides Long-term Benefits for Patients with Heart Failure

21 Mar 2023 11:02:23 By Nasdaq GlobeNewswire

CVRx Reiterates Plans to Discuss the Preliminary Results from the Post-Market Phase of the BeAT-HF Trial at THT 2023 and Schedules a Conference Call

16 Mar 2023 08:30:00 By Nasdaq GlobeNewswire

CVRx Reports Preliminary Results of the BeAT-HF Post-Market Randomized Clinical Trial

21 Feb 2023 07:00:00 By Nasdaq GlobeNewswire

CVRx Reports Fourth Quarter and Full Year 2022 Financial and Operating Results

26 Jan 2023 16:15:00 By Nasdaq GlobeNewswire

CVRx to Report Fourth Quarter and Fiscal Year 2022 Financial and Operating Results and Host Conference Call on January 26, 2023

12 Jan 2023 17:30:00 By Nasdaq GlobeNewswire

CVRx to Present at the 41st Annual J.P. Morgan Healthcare Conference

28 Dec 2022 08:30:00 By Nasdaq GlobeNewswire

CVRx Appoints Industry Veteran Kevin Hykes to Board of Directors

20 Dec 2022 16:05:00 By Nasdaq GlobeNewswire

CVRx to Present at the Piper Sandler 34th Annual Healthcare Conference

16 Nov 2022 08:00:01 By Nasdaq GlobeNewswire

CVRx Launches new Barostim NEO2™ Implantable Pulse Generator

03 Nov 2022 10:31:37 By Nasdaq GlobeNewswire

CVRx to Attend Upcoming Investor Conferences

03 Nov 2022 08:30:00 By Nasdaq GlobeNewswire

CVRx Reports Third Quarter 2022 Financial and Operating Results

01 Nov 2022 16:15:00 By Nasdaq GlobeNewswire

CVRx to Report Third Quarter 2022 Financial and Operating Results and Host Conference Call on November 1st, 2022

18 Oct 2022 16:30:00 By Nasdaq GlobeNewswire

CVRx to Present at the Canaccord Genuity 42nd Annual Growth Conference

29 Jul 2022 08:30:00 By Nasdaq GlobeNewswire

CVRx Reports Second Quarter 2022 Financial and Operating Results

28 Jul 2022 16:10:00 By Nasdaq GlobeNewswire

CVRx to Report Second Quarter 2022 Financial and Operating Results and Host Conference Call

14 Jul 2022 16:30:00 By Nasdaq GlobeNewswire

CVRx Launches a new Barostim™ Programmer

12 Jul 2022 08:30:00 By Nasdaq GlobeNewswire

CVRx to Present at the William Blair 42nd Annual Growth Stock Conference

23 May 2022 16:30:00 By Nasdaq GlobeNewswire

CVRx® Receives MR-Conditional Labeling Approval for its Barostim™ Heart Failure System

09 May 2022 08:30:00 By Nasdaq GlobeNewswire

CVRx Reports First Quarter 2022 Financial and Operating Results

25 Apr 2022 16:05:00 By Nasdaq GlobeNewswire